Thema: KR7185750007
Chong Kun Dang, KR7185750007
business-17610_1920.jpg - Foto: THN
Chong Kun Dang stock secures exclusive Korea CAR-T rights
Chong Kun Dang stock will distribute Nespecel in South Korea if the CAR-T therapy wins approval. AbClon retains development and manufacturing duties.
ad-hoc-news.de, vor 26 Minuten
Chong Kun Dang, KR7185750007
Chong Kun Dang presents CKD-DAC data and analysts rate Chong ...
Seven analysts set a KRW 102,857 target in a three-month survey. Chong Kun Dang stock posted Q2 revenue of KRW 478.47 billion, up 10.00 percent.
ad-hoc-news.de, 20.10.26 01:56 Uhr
Chong Kun Dang, KR7185750007
Chong Kun Dang files patent trials: what it means for Chong ...
